Inhaltsbereich
| 72 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
 Druckansicht
|
| Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. |
| Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O |
| Immunity. 2015 Feb 10. pii: S1074-7613(15)00036-9. doi: 10.1016/j.immuni.2015.01.010. pmc: PMC4361732. mid: EMS62361 |
| PMID: 25680274 |
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
| Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| PMID: 29146401 |
| Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy. |
| Harmankaya K, Erasim C, Koelblinger C, Ibrahim R, Hoos A, Pehamberger H, Binder M |
| Medical oncology (Northwood, London, England). 2010 Jul 1. doi: 10.1007/s12032-010-9606-0 |
| PMID: 20593249 |
| Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans. |
| Langer O, Karch R, Müller U, Dobrozemsky G, Abrahim A, Zeitlinger M, Lackner E, Joukhadar C, Dudczak R, Kletter K, Müller M, Brunner M |
| Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2005 Nov 4. pii: 46/11/1835 |
| PMID: 16269597 |
| Planning and reporting of quality-of-life outcomes in cancer trials. |
| Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Nov 25. pii: mdv559. doi: 10.1093/annonc/mdv559 |
| PMID: 26612098 |
| Planning and reporting of quality-of-life outcomes in cancer trials. |
| Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Jun 30. pii: mdv283. doi: 10.1093/annonc/mdv283. pmc: PMC4551161 |
| PMID: 26133966 |
| Antitumor response and new lesions in advanced melanoma patients on ipilimumab treatment. |
| Wolchok JD, Ibrahim R, DePril V, Maio M, Queirolo P, Harmankaya K, Lundgren L, Hoos A, Humphrey R, Hamid O |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.3020 |
| PMID: 27947620 |
| Novel efficacy criteria for antitumor activity to immunotherapy using the example of ipilimumab, an anti-CTLA-4 monoclonal antibody. |
| Hodi FS, Hoos A, Ibrahim R, Chin K, Pehamberger H, Harmankaya K, O'Day S, Hamid O, Humphrey R, Wolchok J |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.3008 |
| PMID: 27947617 |
| Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study. |
| Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A |
| The European respiratory journal. 2017 Aug 31. pii: 50/2/1700936. doi: 10.1183/13993003.00936-2017 |
| PMID: 28860269 |
| TATTOOS: What Do People Really Know About the Medical Risks of Body Ink? |
| Rahimi IA, Eberhard I, Kasten E |
| The Journal of clinical and aesthetic dermatology. 2018 Mar 1. |
| PMID: 29606998 |
| Ancient goat genomes reveal mosaic domestication in the Fertile Crescent. |
| Daly KG, Maisano Delser P, Mullin VE, Scheu A, Mattiangeli V, Teasdale MD, Hare AJ, Burger J, Verdugo MP, Collins MJ, Kehati R, Erek CM, Bar-Oz G, Pompanon F, Cumer T, Çakırlar C, Mohaseb AF, Decruyenaere D, Davoudi H, Çevik Ö, Rollefson G, Vigne JD, Khazaeli R, Fathi H, Doost SB, Rahimi Sorkhani R, Vahdati AA, Sauer EW, Azizi Kharanaghi H, Maziar S, Gasparian B, Pinhasi R, Martin L, Orton D, Arbuckle BS, Benecke N, Manica A, Horwitz LK, Mashkour M, Bradley DG |
| Science (New York, N.Y.). pii: 361/6397/85. doi: 10.1126/science.aas9411 |
| PMID: 29976826 |
| Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial. |
| Carlino MS, Long GV, Schadendorf D, Robert C, Ribas A, Richtig E, Nyakas M, Caglevic C, Tarhini A, Blank C, Hoeller C, Bar-Sela G, Barrow C, Wolter P, Zhou H, Emancipator K, Jensen EH, Ebbinghaus S, Ibrahim N, Daud A |
| European journal of cancer (Oxford, England : 1990). 2018 Aug 7. pii: S0959-8049(18)30948-1. doi: 10.1016/j.ejca.2018.06.034 |
| PMID: 30096704 |
| Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. |
| Hamid O, Robert C, Ribas A, Hodi FS, Walpole E, Daud A, Arance AS, Brown E, Hoeller C, Mortier L, Schachter J, Long J, Ebbinghaus S, Ibrahim N, Butler M |
| British journal of cancer. 2018 Sep 11. doi: 10.1038/s41416-018-0207-6. pii: 10.1038/s41416-018-0207-6 |
| PMID: 30202085 |
| Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis. |
| Cassese S, Wolf F, Ingwersen M, Kinstner CM, Fusaro M, Ndrepepa G, Ibrahim T, Ott I, Lammer J, Krankenberg H, Fusaro M |
| Circulation. Cardiovascular interventions. doi: 10.1161/CIRCINTERVENTIONS.118.007055 |
| PMID: 30562083 |
| • Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected. |
| Kappel-Latif S, Zacherl J, Hejna M, Westerhoff M, Tamandl D, Ba-Ssalamah A, Mittlböck M, Wolf B, Wrba F, Kührer I, Pluschnig U, Schoppmann SF, Függer R, Zwrtek R, Glaser K, Karner J, Längle F, Wenzl E, Roka R, Öfner D, Tschmelitsch J, Hold M, Keil F, Gnant M, Kandioler D |
| European surgery : ACA : Acta chirurgica Austriaca. 2018 Jun 11. doi: 10.1007/s10353-018-0527-z. pii: 527. pmc: PMC6290852 |
| PMID: 30559831 |
| Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer. |
| Canonici A, Browne AL, Ibrahim MFK, Fanning KP, Roche S, Conlon NT, O'Neill F, Meiller J, Cremona M, Morgan C, Hennessy BT, Eustace AJ, Solca F, O'Donovan N, Crown J |
| Therapeutic advances in medical oncology. 2020 Jan 28. doi: 10.1177/1758835919897546. pii: 10.1177_1758835919897546. pmc: PMC6987485 |
| PMID: 32064003 |
| Efficacy of lenvatinib in patients with advanced pancreatic (panNETs) and gastrointestinal (giNETs) grade 1/2 (G1/G2) neuroendocrine tumors: Results of the international phase II TALENT trial (GETNE 1509). |
| Capdevila J, Fazio N, Lopez C, Teule A, Valle JW, Tafuto S, Custodio A, Reed N, Raderer M, Grande E, Garcia-Carbonero R, Jimenez Fonseca P, Alonso V, Antonuzzo L, Spallanzani A, Berruti A, Sevilla Garcia I, La Casta A, Hernando J, Ibrahim T |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)49922-5. doi: 10.1093/annonc/mdy293 |
| PMID: 32137197 |
| Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. |
| O'Day SJ, Maio M, Chiarion-Sileni V, Gajewski TF, Pehamberger H, Bondarenko IN, Queirolo P, Lundgren L, Mikhailov S, Roman L, Verschraegen C, Humphrey R, Ibrahim R, de Pril V, Hoos A, Wolchok JD |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2010 Feb 10. pii: S0923-7534(19)39410-4. doi: 10.1093/annonc/mdq013 |
| PMID: 20147741 |
| Catching Common Cold Virus with a Net: Pyridostatin Forms Filaments in Tris Buffer That Trap Viruses-A Novel Antiviral Strategy? |
| Real-Hohn A, Zhu R, Ganjian H, Ibrahim N, Hinterdorfer P, Kowalski H, Blaas D |
| Viruses. 2020 Jul 4. pii: v12070723. doi: 10.3390/v12070723 |
| PMID: 32635420 |
| Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study. |
| Jones E, Hummerich H, Viré E, Uphill J, Dimitriadis A, Speedy H, Campbell T, Norsworthy P, Quinn L, Whitfield J, Linehan J, Jaunmuktane Z, Brandner S, Jat P, Nihat A, How Mok T, Ahmed P, Collins S, Stehmann C, Sarros S, Kovacs GG, Geschwind MD, Golubjatnikov A, Frontzek K, Budka H, Aguzzi A, Karamujić-Čomić H, van der Lee SJ, Ibrahim-Verbaas CA, van Duijn CM, Sikorska B, Golanska E, Liberski PP, Calero M, Calero O, Sanchez-Juan P, Salas A, Martinón-Torres F, Bouaziz-Amar E, Haïk S, Laplanche JL, Brandel JP, Amouyel P, Lambert JC, Parchi P, Bartoletti-Stella A, Capellari S, Poleggi A, Ladogana A, Pocchiari M, Aneli S, Matullo G, Knight R, Zafar S, Zerr I, Booth S, Coulthart MB, Jansen GH, Glisic K, Blevins J, Gambetti P, Safar J, Appleby B, Collinge J, Mead S |
| The Lancet. Neurology. pii: S1474-4422(20)30273-8. doi: 10.1016/S1474-4422(20)30273-8 |
| PMID: 32949544 |
| 72 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
